Mrinal M. Gounder, MD
Associate Attending Physician
Memorial Sloan Kettering Cancer Center and Weill Cornell Medical Center
New York, New York, United States
Patrick Schöffski, MD, MPH
Head Department of General Medical Oncology
Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Leuven Cancer Institute
Leuven, Vlaams-Brabant, Belgium
Noboru Yamamoto, MD, PhD
Department of Experimental Therapeutics, National Cancer Center Hospital
Tokyo, Tokyo, Japan
Todd M. Bauer, MD
Sarah Cannon Research Institute, Tennessee Oncology
Nashville, Tennessee, United States
Manish R. Patel, MD
Sarah Cannon Research Institute, Florida Cancer Specialists & Research Institute
Sarasota, Florida, United States
Junxian Geng, PhD
Principal Clinical Data Scientist
Boehringer Ingelheim Pharmaceuticals, Inc.
Ridgefield, Connecticut, United States
Sara Durland-Busbice, n/a
Boehringer Ingelheim Pharmaceuticals Inc
Ridgefield, Connecticut, United States
Michael Teufel, PhD (he/him/his)
Executive Director
Boehringer Ingelheim Pharmaceuticals, Inc.
Ridgefield, Connecticut, United States
Girish Jayadeva, MBBS, PhD
Boehringer Ingelheim International GmbH
Ingelheim am Rhein, Rheinland-Pfalz, Germany
Patricia LoRusso, PhD
Yale University School of Medicine, Yale Cancer Center
New Haven, Connecticut, United States